-
The 23rd European Meeting on HIV & Hepatitis 2025 will be held from 4-6 June 2025 in Barcelona, Spain. For this edition of the meeting, we will be returning to the Hotel Catalonia Barcelona Plaza, Barcelona, Spain to host this valuable program. Please find more information regarding the location below under the "Venue" tab.
-
The Abstract Submission Portal is open! Click here for more information about abstracts.
- Registration to the 23rd European Meeting on HIV & Hepatitis 2025 is open. Registration waivers and discounts are available for specific categories. Click here for fees and conditions.
- The enduring materials of the European Meeting on HIV & Hepatitis 2024 are available here.
-
To stay updated on the relevant developments, make sure you are signed up for our newsletter.
Meeting category
Date(s)
4 Jun 2025 - 6 Jun 2025
Important dates
Early Registration Deadline
Friday, 3 January 2025 at 23:59 CET
Abstract Submission Deadline
Friday, 28 February 2025 at 23:59 CET
Location
Barcelona,
Spain
Meeting type
In-Person Meeting
23rd European Meeting on HIV & Hepatitis 2025
General
What's New
About this Program
It is our pleasure to confirm that the 23rd Edition of the European Meeting on HIV & Hepatitis will take place as a live meeting on 4-6 June 2025 in Barcelona, Spain.
Founded more than twenty years ago as the European HIV Resistance Workshop, the European Meeting on HIV & Hepatitis - Treatment Strategies & Antiviral Drug Resistance has evolved to embrace all aspects of the clinical care of people living with HIV in Europe. This workshop places emphasis in particular on optimal treatment strategies, clinical virology, molecular epidemiology, and public health aspects of HIV, HBV, HCV, as well as emerging viruses throughout Europe.
In the last decade, the meeting has been able to capture leading clinicians and researchers from different regions of Europe. As such, this meeting is the only European platform where HIV-treating physicians and clinical virologists get together on an annual basis to present their latest research results and discuss their clinical implications in detail.
General Information
Who Should Attend?
Primary: Europe-based clinicians/physicians and researchers involved in the fields of HIV, HBV, and HCV.
Secondary: Laboratory managers, technicians, pharmacists, and pharmacologists.
- Residents, post-graduates, and PhD students
- Government agency personnel, NGO representatives, and health authority personnel
- Industry representatives
- Social workers, advocates, and community workers
- Other healthcare professionals involved in treating HIV and co-infected patients
Secondary: Laboratory managers, technicians, pharmacists, and pharmacologists.
- Residents, post-graduates, and PhD students
- Government agency personnel, NGO representatives, and health authority personnel
- Industry representatives
- Social workers, advocates, and community workers
- Other healthcare professionals involved in treating HIV and co-infected patients
Meeting Objectives
This meeting aims to:
- Gather professionals in the fields of HIV and hepatitis clinical care and research in an interactive workshop setting;
- Provide a platform for presentation and discussion of the latest developments in the field of antiviral drug development;
- Map important current studies and results;
- Translate new data into treatment guidelines; and
- Educate clinicians on how to best implement current and new drugs in clinical practice.
- Gather professionals in the fields of HIV and hepatitis clinical care and research in an interactive workshop setting;
- Provide a platform for presentation and discussion of the latest developments in the field of antiviral drug development;
- Map important current studies and results;
- Translate new data into treatment guidelines; and
- Educate clinicians on how to best implement current and new drugs in clinical practice.
Learning Objectives
After participating in this activity, participants will be able to:
- Summarize recent results (including clinical trial results) in drug development for HIV or Hepatitis;
- Apply the latest scientific results into daily clinical care to improve the quality of life of individuals living with HIV; and
- Identify future challenges in the screening, monitoring and diagnosis of patients living with HIV or Hepatitis and develop new concepts for research and care strategies.
- Summarize recent results (including clinical trial results) in drug development for HIV or Hepatitis;
- Apply the latest scientific results into daily clinical care to improve the quality of life of individuals living with HIV; and
- Identify future challenges in the screening, monitoring and diagnosis of patients living with HIV or Hepatitis and develop new concepts for research and care strategies.
Practical Information
Venue
The confirmed venue for the 23rd European Meeting on HIV & Hepatitis 2025 is at the following location:
Hotel Catalonia Barcelona Plaza
Pl. d'Espanya, 8, Sants-Montjuïc
08014 Barcelona
Spain
Distance from Barcelona Airport (BCN): 13 km
Hotel Catalonia Barcelona Plaza
Pl. d'Espanya, 8, Sants-Montjuïc
08014 Barcelona
Spain
Distance from Barcelona Airport (BCN): 13 km
Accommodation
Accommodation is not included in the registration fee.
Badges
All participants are requested to wear the badge at all times during the conference to ensure admission to the meeting.
Certificate of Attendance
A certificate of attendance will be sent to you after successfully completing the program and post-meeting survey.
Language
The official language of the meeting is English
Translation will not be provided.
Translation will not be provided.
Meeting Materials
Meeting materials can be obtained upon registration at the registration desk at the Meeting Venue.
Disclaimer
This meeting is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this event, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the conference.
Liability and Insurance
By registering for the meeting participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Photographs, Audio, and Video Recording
Photographs, audio, and video recordings are not permitted at the official meeting sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the workshop is finished, provided the speaker has given permission to do so.
Code of Conduct
All attendees, speakers, co-organizers, partners, endorsers, suppliers, volunteers, and employees at any of our programs are expected to observe our Code of Conduct. We cannot tolerate any form of discrimination, harassment, disrespect, or the marginalization of those involved in our programs. All participants of VE and AME-organized programs are expected to treat others with dignity and respect at all times.
Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.
Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.
Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Registration
Register with the Early Fee Now!
Fees and Conditions
Registration Fees
|
Regular Delegates |
Industry Delegates |
|
|---|---|---|
|
Early Fee (payment before/on 3 January 2025) |
€595 |
€1,195 |
|
Standard Fee (payment before/on 4 April 2025) |
€745 |
€1,495 |
|
Late Fee (payment from 5 April 2025) |
€795 |
€1,795 |
|
Fee Waivers |
|
|---|---|
|
Abstract Submitters who are eligible as: |
50% discount on the Early Fee |
|
Abstract Submitters who are eligible as "Regular delegates" from a High Income Countries |
Early applicable fee |
|
Early-Career Investigators (ECI) & "Regular Delegates" from a Resource-Limited Setting (RLS) |
50% discount on the current applicable fee |
|
Representatives of Endorsing Organizations |
25% discount on the current applicable fee |
|
Representatives of Sponsoring Industry |
Please contact the meeting secretariat |
|
Financial Concerns |
If you have financial concerns, please contact the meeting secretariat |
*Countries included in the low-income and middle-income economies list of the World Bank Classification
Important
-
We strongly advise that you register early to ensure your registration. Registration will close when the capacity of the venue is reached.
-
Submission of your online registration does not guarantee that your registration has been accepted. Your registration is final when full prepayment has been received and a confirmation of your registration has been sent.
Registration Fee Includes
- Access to all scientific sessions, including poster area;
- Conference pack, including digital abstract book and printed program book;
- Refreshments during the coffee breaks;
- Buffet lunch on meeting days;
- Complimentary entrance to the Networking Reception*
- Access to all enduring materials
* The Networking Reception will take place in the same venue of the meeting and will not have any music / entertainment of any shape or form. The Networking Reception only offers finger foods and the opportunity to have a look at the chosen abstract poster presentations.
IMPORTANT:
- No day rate is available
- Virology Education reserves the right to cancel improper registrations. Claims for a refund will not be honored.
- Conference pack, including digital abstract book and printed program book;
- Refreshments during the coffee breaks;
- Buffet lunch on meeting days;
- Complimentary entrance to the Networking Reception*
- Access to all enduring materials
* The Networking Reception will take place in the same venue of the meeting and will not have any music / entertainment of any shape or form. The Networking Reception only offers finger foods and the opportunity to have a look at the chosen abstract poster presentations.
IMPORTANT:
- No day rate is available
- Virology Education reserves the right to cancel improper registrations. Claims for a refund will not be honored.
Group Registration
For registration of groups larger than 5 participants, please contact the meeting secretariat at Michelle.Wu@amededu.com.
Early-Career Investigators / Regular Delegate from Resource-limited Settings (RLS)
To be eligible as an early-career investigator, one should either be:
- A current Master/PhD student; OR
- Have obtained an MD/PharmD/PhD degree in the last five years.
An application form needs to be completed by a supervisor and received by the Virology Education secretariat at least two weeks prior to the start of the workshop. Virology Education will contact the early-career investigator with instructions regarding the registration procedure.
Please find the forms below.
- A current Master/PhD student; OR
- Have obtained an MD/PharmD/PhD degree in the last five years.
An application form needs to be completed by a supervisor and received by the Virology Education secretariat at least two weeks prior to the start of the workshop. Virology Education will contact the early-career investigator with instructions regarding the registration procedure.
Please find the forms below.
Payment
By credit card only: online or by written authorization (see online registration).
Please contact the Secretariat at Michelle.Wu@amededu.com if you need to make alternative arrangements.
Please contact the Secretariat at Michelle.Wu@amededu.com if you need to make alternative arrangements.
Cancellation Policy
In case of cancellation, the following refunds are applicable:
- Cancellation before/on 4 May 2025: 50% refund (minus an administration fee of €40)
- Cancellation after 4 May 2025: Unfortunately, no refund will be given
If you are unable to attend the conference, a substitute delegate is always welcome at no extra charge, provided that a letter of authorization from the original participant has been received and the conference secretariat has been notified of the name of the substitute delegate before 21 May 2025. A statement (email/letter) of cancellation must be sent to Virology Education.
- Cancellation before/on 4 May 2025: 50% refund (minus an administration fee of €40)
- Cancellation after 4 May 2025: Unfortunately, no refund will be given
If you are unable to attend the conference, a substitute delegate is always welcome at no extra charge, provided that a letter of authorization from the original participant has been received and the conference secretariat has been notified of the name of the substitute delegate before 21 May 2025. A statement (email/letter) of cancellation must be sent to Virology Education.
Liability and Insurance
By registering for the conference, participants agree that the organizers do not accept responsibility for medical, travel, or personal insurance. Participants are advised to take out their own insurance policies.
Media Registration
In order to register as a media participant for the Conference, the conference secretariat needs to receive:
1. Proof of accreditation
2. Valid identification (e.g. passport)
3. A letter from your assignment giver stating the details of your assignment (e.g. editor)
4. At least 3 previous written assignments in recognized outlets on HIV. If you are a freelance journalist, the assignments can be from different (recognizable) news outlets. Links to online publications are accepted
5. The website of the publication(s)/blog(s) that will be featuring your story on this workshop
A complimentary or reduced registration fee may apply for accredited media participants depending on availability. Preference will be given to credible print and online news sources. Please contact the conference secretariat for registration conditions.
We would like to receive a copy of your workshop report/ article once it is finalized.
All credentials will be verified by the Organizing Committee of the Workshop. Media representatives are kindly requested to register by sending the above-mentioned information to info@amededu.com.
Important: Media is restricted to the written press. Recording on film or photo is not allowed. Virology Education will request a copy of the written piece once it is finalized. Media representatives must also agree to abide by the 2020 embargo policy.
1. Proof of accreditation
2. Valid identification (e.g. passport)
3. A letter from your assignment giver stating the details of your assignment (e.g. editor)
4. At least 3 previous written assignments in recognized outlets on HIV. If you are a freelance journalist, the assignments can be from different (recognizable) news outlets. Links to online publications are accepted
5. The website of the publication(s)/blog(s) that will be featuring your story on this workshop
A complimentary or reduced registration fee may apply for accredited media participants depending on availability. Preference will be given to credible print and online news sources. Please contact the conference secretariat for registration conditions.
We would like to receive a copy of your workshop report/ article once it is finalized.
All credentials will be verified by the Organizing Committee of the Workshop. Media representatives are kindly requested to register by sending the above-mentioned information to info@amededu.com.
Important: Media is restricted to the written press. Recording on film or photo is not allowed. Virology Education will request a copy of the written piece once it is finalized. Media representatives must also agree to abide by the 2020 embargo policy.
Disclaimer
This workshop is intended for educational purposes only and aims to offer participants the opportunity to share information. The organizing secretariat of this workshop, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this workshop. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the workshop. In case of cancellation of the meeting due to unforeseen circumstances, Virology Education cannot be held responsible for expenses made for travel, accommodation, visa applications, etc.
Program
Preliminary Program
Please find below the Preliminary Program of the Meeting.
Wednesday, 4 June 2025
- 14:00
14:00 CEST
Opening Words
Session 1: Implementation of HIV Prevention in Europe - 14:05
14:05 CEST
Efficacy, Toxicity and adherence considerations
14:20 CEST
Logistical / Infrastructure Considerations
14:35 CEST
Price Considerations
14:50 CEST
Panel Discussion: Should Superiority Entail Immediate Implementation?
15:35 CEST
Coffee Break & Poster Viewing
Session 2: Multipurpose Prevention Strategies - 16:05
16:05 CEST
Combination Prevention in Infectious Disease
16:25 CEST
Oral Abstract Presentations
16:45 CEST
Discussion
Guided Poster Tour & Networking Reception - 17:05
17:05 CEST
Guided Poster Tour 1
18:00 CEST
Networking Reception
Thursday, 5 June 2025
Session 3: HIV Drug Resistance - 9:00
9:00 CEST
Charles Boucher Lecture: Clinically Relevant Interpretation of Capsid Inhibitor Resistance
9:20 CEST
Update on Resistance to Integrase Inhibitors: Resource Rich versus Resource Limited Settings
9:40 CEST
Oral Abstract Presentations
10:30 CEST
Discussion
11:00 CEST
Coffee Break & Poster Viewing
Session 4: Improving the Clinical Utility of HIV / Hepatitis Drug Resistance Assay Results - 11:45
11:45 CEST
How to Improve Fruitful Dialogue between the Virology Lab and Clinicians
Clinician Perspective
Lab Manager Perspective
12:15 CEST
Andrea de Luca Lecture: Future of Interpretation Drug Resistance (Regimens)
12:35 CEST
Oral Abstract Presentations
12:55 CEST
Discussion
13:15 CEST
Lunch
Industry-Supported Symposium - 14:15
14:15 CEST
Industry-Supported Symposium
15:15 CEST
Coffee Break & Poster Viewing
Session 5: Viral Hepatitis - HCV Viral Hepatitis - 16:15
16:15 CEST
Why Do We Still Have the Gaps (Epid.) - Micro-Elimination Approaches / Screening Strategies in High-Risk Populations
16:35 CEST
Micro-Elimination Approaches - IV Drug Users
16:50 CEST
Micro-Elimination Approaches - MSM
17:05 CEST
Oral Abstract Presentations
17:35 CEST
Discussion
Guided Poster Tour & Networking Dinner - 17:55
17:55 CEST
Guided Poster Tour 2
20:00 CEST
Networking Dinner
Friday, 6 June 2025
Session 6: Viral Hepatitis - HBV - 9:00
Anna Maria Geretti, MD, PhD, FRCPath
9:00 CEST
Risk for Re-Activation
University of Rome, Italy / King's College London, United Kingdom
9:20 CEST
Update Novel Compounds HBV / HDV & Biomarkers
09:40 CEST
Oral Abstract Presentations
10:10 CEST
Discussion
10:30
Coffee Break & Poster Viewing
Session 7: What’s in the Pipeline? Presentations on Future Viral Therapeutics and Vaccines from Scientists from Industry -
The full program of "Session 7" can be visited under the "Industry Program" Tab
12:30 CEST
Lunch
Session 8: Hot Topics - 13:30
13:30 CEST
APOBEC / Restriction Factors Influence on the Development of Variants
13:50 CEST
Debate: Time to Forego Baseline Resistance Testing in Treatment Naïve European PLWHIV?
PRO Standpoint
CON Standpoint
14:20 CEST
Transmission Networks - Translation in Public Health Policies
14:40 CEST
Discussion
15:00 CEST
Closure of the Workshop and Ricardo Camacho Awards
15:15 CEST
End of the Meeting
Industry Program
Please find below the program of the Industry Sessions that are part of the Meeting
Friday, 6 June 2025
Session 7: What’s in the Pipeline? Presentations on Future Viral Therapeutics and Vaccines from Scientists from Industry
- 11:00
Calvin Cohen, MD, MSc
Harmony Garges, MD, MPH
11:00 CEST
Gilead Sciences
Executive Director, Global HIV Medical Affairs, Gilead Sciences, United States
11:20 CEST
ViiV Healthcare
Senior Vice President, Chief Medical Officer and Head of Global Medical, ViiV Healthcare, United States
11:40 CEST
MSD
12:00 CEST
Discussion
12:30 CEST
Lunch
Abstracts
Abstract Submission Deadline: Friday, 28 February 2025 at 23:59 CET
Abstracts
- The European Meeting on HIV & Hepatitis 2025 accepts new original data as well as encored abstracts. All abstracts must focus on the European region and contain up-to-date information at the time of the meeting.
- Early-Career Investigators (ECI) or "Regular Delegate" from Resource-Limited Setting (RLS) with an accepted abstract are able to receive a 50% discount off of the early registration fee. The requirements for the application are specified here.
-
Abstract submitters are strongly encouraged to use person-first language in their abstracts. View the video tutorial and guidelines here
-
Abstract presenters are expected to attend the meeting in-person to present their abstract.
Please contact the meeting secretariat if this is not possible.
Image
Categories for Abstract Submission
For purposes of review and programming, abstracts are divided into topical categories. The selection of the most appropriate category is important as it determines who reviews your abstract. The Reviewing Committee reserves the right to reassign your abstract to a more appropriate category. Click here for an overview of the categories.
Abstract Categories:
- Clinical Case
- Clinical Implications of Antiviral Drug Resistance (Hepatitis B, Hepatitis C and HIV)
- Clinical Research on HIV and Co-Infections
- HIV Inflammation and Cure
- HIV Prevention, Strategies and Implementation
- Management of COVID-19 and Other Respiratory Viruses
- Mechanism of Antiviral Drug Resistance (Hepatitis B, Hepatitis C and HIV)
- Novel Diagnostic Technologies & Approaches
- Resistance to Antiviral Drugs (Hepatitis B, Hepatitis C and HIV)
- Spread of Drug Resistance
- Therapeutic Challenges in Resource-Limited Settings
- Treatment Strategies for People Living with HIV / Hepatitis
- Viral Evolution & Genetic Diversity
Abstract Categories:
- Clinical Case
- Clinical Implications of Antiviral Drug Resistance (Hepatitis B, Hepatitis C and HIV)
- Clinical Research on HIV and Co-Infections
- HIV Inflammation and Cure
- HIV Prevention, Strategies and Implementation
- Management of COVID-19 and Other Respiratory Viruses
- Mechanism of Antiviral Drug Resistance (Hepatitis B, Hepatitis C and HIV)
- Novel Diagnostic Technologies & Approaches
- Resistance to Antiviral Drugs (Hepatitis B, Hepatitis C and HIV)
- Spread of Drug Resistance
- Therapeutic Challenges in Resource-Limited Settings
- Treatment Strategies for People Living with HIV / Hepatitis
- Viral Evolution & Genetic Diversity
General Guidelines
Abstracts should contain the following four components:
- Background: A concise statement of the issue under investigation or a hypothesis;
- Material and Methods: The experimental methods used (including the statistical analyses employed);
- Results: Specific findings (promises such as "to be completed" or "to be presented" are not acceptable);
- Conclusions: A summary of findings that are supported by your results (statistical analyses used to support the conclusions, where appropriate, should be included; concluding statements such as "the results will be discussed" are not acceptable).
Please note that abstracts cannot be accepted if tables or graphs are included. The maximum word count for the abstract body is 500 words.
Abstracts are considered official communications to the conference and will be treated confidentially. Submitters of accepted abstracts agree to attend the meeting and present their abstract as scheduled.
We encourage you to use person-first language in your abstract(s). View our guidelines here: https://academicmedicaleducation.com/person-first-language
- Background: A concise statement of the issue under investigation or a hypothesis;
- Material and Methods: The experimental methods used (including the statistical analyses employed);
- Results: Specific findings (promises such as "to be completed" or "to be presented" are not acceptable);
- Conclusions: A summary of findings that are supported by your results (statistical analyses used to support the conclusions, where appropriate, should be included; concluding statements such as "the results will be discussed" are not acceptable).
Please note that abstracts cannot be accepted if tables or graphs are included. The maximum word count for the abstract body is 500 words.
Abstracts are considered official communications to the conference and will be treated confidentially. Submitters of accepted abstracts agree to attend the meeting and present their abstract as scheduled.
We encourage you to use person-first language in your abstract(s). View our guidelines here: https://academicmedicaleducation.com/person-first-language
Abstract Submission
Authors can submit their abstracts electronically until the deadline. You will be redirected to the submission website. Please follow the step-by-step directions to upload the abstract. To ensure your abstract retains any special characters or formatting, the abstract must be in Microsoft Word format.
Poster Presentation Instructions
Note: Poster presenters are expected to attend onsite.
Posters need to meet the following requirements:
- Print Size: A0 size (approx. 33" x 47"), printed in portrait format.
- Please display the number of your poster in the upper right corner of your poster.
- Please refrain from printing your poster on textile/fabric, as it will not be able to stick well to the poster boards.
- Please hang your posters as early as possible. All posters must be displayed from the opening session to the closure of the meeting.
- Pushpins and/or tape will be provided.
Once onsite:
Poster presenters are requested to stand near their poster(s) during the poster session.
Posters need to meet the following requirements:
- Print Size: A0 size (approx. 33" x 47"), printed in portrait format.
- Please display the number of your poster in the upper right corner of your poster.
- Please refrain from printing your poster on textile/fabric, as it will not be able to stick well to the poster boards.
- Please hang your posters as early as possible. All posters must be displayed from the opening session to the closure of the meeting.
- Pushpins and/or tape will be provided.
Once onsite:
Poster presenters are requested to stand near their poster(s) during the poster session.
Committees
The members of the Organizing Committee are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the workshop, identify interesting topics and candidate speakers, and review all submitted abstracts.
Scientific Program Coordinator
Scientific Committee
Ana B. Abecasis, MD, PhD, PharmD
Global Health and Tropical Medicine, Institute of Hygiene and Tropical Medicine, Universidade NOVA de Lisboa, Portugal
Raquel Martín-Iguacel, MD, PhD
Odense University Hospital, Denmark
Monique Nijhuis, PhD
University Medical Centre Utrecht, the Netherlands
Martin Obermeier, MD
Medizinisches Infektiologiezentrum Berlin, Germany
Mario Poljak, MD, PhD
Institute for Microbiology and Immunology, Slovenia
Anders Sönnerborg, MD, PhD
Karolinska Institute, Sweden
David van de Vijver, PharmD, PhD
Erasmus University Rotterdam, the Netherlands
Maurizio Zazzi, PhD
University of Siena, Italy
The members of Scientific Committee are hand-picked by the Organizing Committee and the conference secretariat based on their significant contributions and commitment to the field. They assist the Organizing Committee by providing them with suggestions for speakers and topics. In addition, members of the Scientific Committee participate in reviewing submitted abstracts, and play an active role during the workshop as moderators and/or chairs of sessions.
Support
Support Our Initiative
Financial backing to the European Meeting on HIV & Hepatitis 2025 helps us deliver an impactful meeting experience to the benefit of healthcare professionals and researchers interested in HIV & Hepatitis in the European region.
This collaboration plays a vital role in both the organizational as well as scientific success of the program.
To show your commitment to the cause, get in touch with us for a tailored support package by contacting Jesper Niesen at Jesper.Niesen@amededu.com or call +31 30 230 7140.
Benefits of Support
By supporting this program, we can offer the following advantages for your company.* Please contact us for the most recent support level benefits for this program.
- Symposium opportunities
- Non-commercial interviews with company representatives
- Verbal acknowledgement during the program
- Discounted and complimentary registrations for your representatives
- Company acknowledgement on digital meeting materials including but not limited to newsletters, flyers, the streaming platform, and our website
- Company acknowledgement on printed meeting materials including but not limited to banners and the program book
- Digital and printed advertising opportunities
- Social media shout-outs
- Logo on the conference bag
*Subject to the support level.
Endorsers
The 23rd European Meeting on HIV & Hepatitis 2025 is endorsed by societies and organizations. Their support and collaboration are key to the success of this workshop.
If you would like your organization to endorse this meeting, please contact Michelle Wu at Michelle.Wu@amededu.com
Endorsing Societies and Organizations
BCN Checkpoint
HIVPA
Accreditation
Accreditation has been requested from:
- European Accreditation Council for Continuing Medical Education (EACCME)
Media
Welcome Message 2024
Join us in reliving the highlights of our past event as we look forward to welcoming you to the upcoming European Meeting on HIV & Hepatitis 2025!
Previous Editions
Previous Editions
-
22nd Edition - European Meeting on HIV & Hepatitis, 2024, Spain
-
21st Edition - European Meeting on HIV & Hepatitis, 2023, Italy
-
20th Edition - European Meeting on HIV & Hepatitis, 2022, France (Hybrid)
-
19th Edition - European Meeting on HIV & Hepatitis, 2021, Virtual
-
18th Edition - European Meeting on HIV & Hepatitis, 2020, Virtual
-
17th Edition - European Meeting on HIV & Hepatitis, 2019, Italy
-
16th Edition - European Meeting on HIV & Hepatitis, 2018, Italy
-
14th Edition - European Meeting on HIV & Hepatitis, 2016, Italy
Language
Related Programs
